UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 8, 2026
Accession Number:
0001193125-26-378366
Submission Type:
POS AM
CIK:
0001869105
Company Name:
BridgeBio Oncology Therapeutics, Inc.
File Number:
333-289940